The U.S. Food and Drug Administration (FDA) has approved an at-home starter dose for Leqembi (lecanemab), the Alzheimer's disease therapy jointly developed by Eisai and Biogen, marking a significant step toward improving treatment convenience for patients with early Alzheimer's disease. Until now, patients initiating Leqembi therapy
Jan Vishwas Bill signals a new era of ease of doing business for global pharma investors Government commits $10 bn innovation fund; patent filings up nearly 100% in recent years IPHEX 2026 draws 1,000+ exhibitors and delegates from 50+ countries India's pharmaceutical sector is poised
Granules Life Sciences Receives VAI Classification following US FDA Inspection Granules India Limited today announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), has concluded a recent US FDA inspection of its manufacturing facility at Shamirpet, Telangana, with an inspection classification of Voluntary Action Indicated
In a landmark development for mental health treatment, the United States Food and Drug Administration (US FDA) has approved the first at-home medical device designed to help manage symptoms of depression. The approval represents a major milestone in digital therapeutics and neuromodulation, offering patients a
Investment in Belgium’s Frid Mind Technologies to Advance Stroke Prevention Acquisition of Stake in Israel’s Motion Informatics to Strengthen Stroke Rehabilitation Portfolio Development of advanced Braided Devices for Neurovascular and Peripheral Vascular Care Biorad Medisys Pvt. Ltd. today outlined a series of product development
Medtronic, a global leader in healthcare technology, today announced the launch of its next-generation electrosurgical energy platform in India — the Valleylab™ FT10 series. The new portfolio includes the Valleylab™ FT10 Electrosurgical Generator (VLFT10FXGEN) and the Valleylab™ FT10 Vessel Sealing Generator (VLFT10LSGEN), both of which
Healthium Medtech, a global player in medical devices, focused on products in surgical and post-surgical ecosystem including wound closure, advanced wound care, arthroscopy and infection prevention segments, has announced the appointment of Rajnish Damani as Group Chief Operating Officer (COO). In this newly created leadership
JATIN MAHAJAN Secretary, Association of Diagnostics Manufacturers of India (ADMI) The perception that imported products are superior to Indian-made ones is deeply ingrained in the Indian psyche, rooted more in legacy and sentiment than in objective reality. However, this perception is increasingly outdated. India has made significant
Sahajanand Medical Technologies (SMT), a global leader in cardiovascular device innovation, is pleased to announce the appointment of two new members to its Board of Directors: Harvinder Pal Singh, who will serve as Independent Director, and Priyanka Dhirajlal Cohen, who joins as Non-Executive Director. Harvinder Pal
Granules India Ltd., a vertically integrated pharmaceutical company, today announced its financial results for the quarter ended December 31, 2024. Financial Summary (All numbers in INR Mn., except Margins) QUARTERLY CONSOLIDATED FINANCIALS Q3FY25 Q2FY25 Growth (QoQ) Q3FY24 Growth (YoY) Revenue from Operations 11,377 9,666 18% 11,556 -2% EBITDA 2,303 2,033 13% 2,505 -8% EBITDA % 20% 21% 22% PAT 1,176 972 21% 1,257 -6% PAT % 10% 10% 11% Financial and Business Summary for Q3FY25 The Company voluntarily paused
